159 related articles for article (PubMed ID: 15342139)
1. Cannabinoids blocks tactile allodynia in diabetic mice without attenuation of its antinociceptive effect.
Doğrul A; Gül H; Yildiz O; Bilgin F; Güzeldemir ME
Neurosci Lett; 2004 Sep; 368(1):82-6. PubMed ID: 15342139
[TBL] [Abstract][Full Text] [Related]
2. The effect of WIN 55,212-2, a cannabinoid agonist, on tactile allodynia in diabetic rats.
Ulugol A; Karadag HC; Ipci Y; Tamer M; Dokmeci I
Neurosci Lett; 2004 Nov; 371(2-3):167-70. PubMed ID: 15519750
[TBL] [Abstract][Full Text] [Related]
3. Topical cannabinoid enhances topical morphine antinociception.
Yesilyurt O; Dogrul A; Gul H; Seyrek M; Kusmez O; Ozkan Y; Yildiz O
Pain; 2003 Sep; 105(1-2):303-8. PubMed ID: 14499448
[TBL] [Abstract][Full Text] [Related]
4. Activation of spinal cannabinoid CB2 receptors inhibits neuropathic pain in streptozotocin-induced diabetic mice.
Ikeda H; Ikegami M; Kai M; Ohsawa M; Kamei J
Neuroscience; 2013 Oct; 250():446-54. PubMed ID: 23892011
[TBL] [Abstract][Full Text] [Related]
5. Topical cannabinoid antinociception: synergy with spinal sites.
Dogrul A; Gul H; Akar A; Yildiz O; Bilgin F; Guzeldemir E
Pain; 2003 Sep; 105(1-2):11-6. PubMed ID: 14499415
[TBL] [Abstract][Full Text] [Related]
6. Pronociceptive effects of spinal dynorphin promote cannabinoid-induced pain and antinociceptive tolerance.
Gardell LR; Burgess SE; Dogrul A; Ossipov MH; Malan TP; Lai J; Porreca F
Pain; 2002 Jul; 98(1-2):79-88. PubMed ID: 12098619
[TBL] [Abstract][Full Text] [Related]
7. A cannabinoid agonist, WIN 55,212-2, reduces neuropathic nociception induced by paclitaxel in rats.
Pascual D; Goicoechea C; Suardíaz M; Martín MI
Pain; 2005 Nov; 118(1-2):23-34. PubMed ID: 16213089
[TBL] [Abstract][Full Text] [Related]
8. The additive antinociceptive interaction between WIN 55,212-2, a cannabinoid agonist, and ketorolac.
Ulugöl A; Ozyigit F; Yesilyurt O; Dogrul A
Anesth Analg; 2006 Feb; 102(2):443-7. PubMed ID: 16428540
[TBL] [Abstract][Full Text] [Related]
9. Differential activities of intrathecal MK-801 or morphine to alter responses to thermal and mechanical stimuli in normal or nerve-injured rats.
Wegert S; Ossipov MH; Nichols ML; Bian D; Vanderah TW; Malan TP; Porreca F
Pain; 1997 May; 71(1):57-64. PubMed ID: 9200174
[TBL] [Abstract][Full Text] [Related]
10. Systemic and spinal administration of etanercept, a tumor necrosis factor alpha inhibitor, blocks tactile allodynia in diabetic mice.
Dogrul A; Gul H; Yesilyurt O; Ulas UH; Yildiz O
Acta Diabetol; 2011 Jun; 48(2):135-42. PubMed ID: 21104419
[TBL] [Abstract][Full Text] [Related]
11. Contribution of spinal 5-HT
Aksu AG; Gunduz O; Ulugol A
Can J Physiol Pharmacol; 2018 Jun; 96(6):618-623. PubMed ID: 29406831
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the anti-allodynic effects of combination of a synthetic cannabinoid and a selective noradrenaline re-uptake inhibitor in nerve injury-induced neuropathic mice.
Gunduz O; Topuz RD; Karadag CH; Ulugol A
Eur J Pain; 2016 Mar; 20(3):465-71. PubMed ID: 26206340
[TBL] [Abstract][Full Text] [Related]
13. The synthetic cannabinoids attenuate allodynia and hyperalgesia in a rat model of trigeminal neuropathic pain.
Liang YC; Huang CC; Hsu KS
Neuropharmacology; 2007 Jul; 53(1):169-77. PubMed ID: 17572451
[TBL] [Abstract][Full Text] [Related]
14. Activation of peripheral cannabinoid receptors attenuates cutaneous hyperalgesia produced by a heat injury.
Johanek LM; Simone DA
Pain; 2004 Jun; 109(3):432-442. PubMed ID: 15157704
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain.
Toth CC; Jedrzejewski NM; Ellis CL; Frey WH
Mol Pain; 2010 Mar; 6():16. PubMed ID: 20236533
[TBL] [Abstract][Full Text] [Related]
16. Physiological evidence of a postsynaptic inhibition of the tail flick reflex by a cannabinoid receptor agonist.
Dableh LJ; Yashpal K; Henry JL
Eur J Pharmacol; 2009 Jan; 602(1):36-40. PubMed ID: 19027734
[TBL] [Abstract][Full Text] [Related]
17. Sustained antinociceptive effect of cannabinoid receptor agonist WIN 55,212-2 over time in rat model of neuropathic spinal cord injury pain.
Hama A; Sagen J
J Rehabil Res Dev; 2009; 46(1):135-43. PubMed ID: 19533526
[TBL] [Abstract][Full Text] [Related]
18. Characterization of cannabinoid-induced relief of neuropathic pain in rat models of type 1 and type 2 diabetes.
Vera G; López-Miranda V; Herradón E; Martín MI; Abalo R
Pharmacol Biochem Behav; 2012 Aug; 102(2):335-43. PubMed ID: 22609797
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic interaction between cannabinoid and either clonidine or neostigmine in the rat formalin test.
Yoon MH; Choi JI
Anesthesiology; 2003 Sep; 99(3):701-7. PubMed ID: 12960556
[TBL] [Abstract][Full Text] [Related]
20. Ultra-low dose naltrexone enhances cannabinoid-induced antinociception.
Paquette J; Olmstead MC
Behav Pharmacol; 2005 Dec; 16(8):597-603. PubMed ID: 16286810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
